caVos Biotherapeutics

Novel Anti-cancer Drugs

Health Tech & Life Sciences

Active

Seed Jerusalem Founded 2021

Total raised

$3.3M

Last: Seed 2024-11

Stage

Seed

Founded

2021

Headcount

Jerusalem

Sector

Health Tech & Life Sciences

About

Cavos Biotech is developing a multi-level genomic algorithm to uncover the genetic base of extraordinary cancer resistance found across various and specific animals.

Harnessing the latest in data and genomics, the company uses high-resolution identification methods to uncover existing anti-cancer mechanisms and novel drug targets in order to revolutionize the way drug targets are discovered and identified.

Funding history · 2 rounds · $3.3M total

2024-11

Seed $3.3M

2021-10

Seed Undisclosed

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development

Technologies

BiologicalsGenes

Target customers

Healthcare & Life SciencesLife SciencesPharmaceuticals

Business model

B2B

Highlights

Verified

Name	caVos Biotherapeutics
Slug	cavos-biotherapeutics
Type	Israeli Startup
Founded	2021
HQ city	Jerusalem
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object]
Status	active
Current stage	Seed
Public stage	Seed
Total raised (USD)	3,300,000
Last round	Seed (2024-11)
Israeli Companies Registrar	516373156

Date	Round	Amount	Lead investors	All investors	Valuation
2021-10	Seed	Undisclosed		aMoon Fund
2024-11	Seed	$3,300,000	Entrée Capital	Entrée Capital, Alumni Ventures, Israel Innovation Authority , NFX Capital, Tal Ventures

Name	Role	LinkedIn
Ohad Tarcic
Yuval Tabach

caVos Biotherapeutics

About

Funding history · 2 rounds · $3.3M total

Sectors & technology

Highlights

Tags